1. Home
  2. NYAX vs SLNO Comparison

NYAX vs SLNO Comparison

Compare NYAX & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nayax Ltd.

NYAX

Nayax Ltd.

HOLD

Current Price

$51.30

Market Cap

2.1B

Sector

N/A

ML Signal

HOLD

Logo Soleno Therapeutics Inc.

SLNO

Soleno Therapeutics Inc.

BUY

Current Price

$37.81

Market Cap

2.3B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
NYAX
SLNO
Founded
2005
1999
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.3B
IPO Year
2022
2014

Fundamental Metrics

Financial Performance
Metric
NYAX
SLNO
Price
$51.30
$37.81
Analyst Decision
Buy
Strong Buy
Analyst Count
5
10
Target Price
$47.50
$112.70
AVG Volume (30 Days)
10.9K
1.3M
Earning Date
01-01-0001
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
108.90
EPS
N/A
0.39
Revenue
N/A
$1,450,788.00
Revenue This Year
$29.95
N/A
Revenue Next Year
$23.27
$158.06
P/E Ratio
$89.78
$105.15
Revenue Growth
N/A
138.82
52 Week Low
$32.38
$36.67
52 Week High
$60.77
$89.12

Technical Indicators

Market Signals
Indicator
NYAX
SLNO
Relative Strength Index (RSI) 38.43 40.32
Support Level $51.24 N/A
Resistance Level $52.46 $44.60
Average True Range (ATR) 1.56 2.26
MACD -0.84 0.17
Stochastic Oscillator 10.24 56.24

Price Performance

Historical Comparison
NYAX
SLNO

About NYAX Nayax Ltd.

Nayax Ltd is an end-to-end retail technology platform for unattended commerce. It provides consumers with digital, cashless payments, and connected commerce experiences, enhancing consumer conversion and loyalty. Its platform addresses the entire unattended commerce value chain, including a payments infrastructure, a commerce software suite, a consumer engagement platform, and integrated POS devices. The company addresses a broad range of retail verticals, including all types of vending machines, coffee machines, unattended checkout counters, self-service kiosks, ticketing machines, car wash stations, gaming machines, amusement rides, laundromats, EV charging stations, and many more.

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Share on Social Networks: